HCMT
INSY

Highland Capital Management (Texas)’s Insys Therapeutics, Inc. INSY Stock Holding History

Highland Capital Management (Texas)’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-251,165
Closed -$7.19M – 293
2015
Q4 		$7.19M Buy
+251,165
New +$6.96M 0.23% 121

Other funds holding INSY

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Highland Capital Management (Texas)'s INSY Position: Q1 2016 in Review

Highland Capital Management (Texas) sold out of Insys Therapeutics, Inc. (INSY) in Q1 2016, closing a stake of 251,165 shares — an estimated $7.19M sold.

Highland Capital Management (Texas) first reported a position in INSY in Q4 2015 and held it in 1 quarter. The position peaked at $7.19M in Q4 2015. 138 funds tracked by Wall St. Rank hold INSY as of Q1 2016.

  • Highland Capital Management (Texas) reported no remaining Insys Therapeutics, Inc. position as of Q1 2016 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 251,165 Insys Therapeutics, Inc. shares in Q1 2016, an estimated $7.19M.
  • Highland Capital Management (Texas) first reported a position in Insys Therapeutics, Inc. in Q4 2015 and held it in 1 quarter.
  • Highland Capital Management (Texas)'s Insys Therapeutics, Inc. position peaked at $7.19M in Q4 2015.
  • 138 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q1 2016.

Based on Highland Capital Management (Texas)'s 13F filing for Q1 2016, filed 16 May 2016.